U.S. market Open. Closes in 1 hour 8 minutes

VYGR | Voyager Therapeutics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for VYGR we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is very poor, Growth is exceptionally good and Health is weak.

Valuation (45%)

Company Industry
P/E Ratio (TTM) 13.21 -20.30
PEG Ratio (TTM) 0.10 -5.71
P/S Ratio (TTM) 1.97 50.88
P/B Ratio (TTM) 1.04 29.28
P/FCF Ratio (TTM) -10.49 -8.95
Price to 5YR AVG Earnings Ratio -846.70 -6.52
Price to 5YR AVG FCF Ratio -25.49 -14.78

Profitability (35%)

Company Industry
ROA (TTM) 6.08% -18.85%
ROE (TTM) 8.33% 25.35%
Net Profit Margin (TTM) 15.80% -827.80%
ROIC 5YR AVG -7.91% -26.10%

Growth (83%)

4QTR AVG 3YR AVG 5YR AVG
EPS 55.61% -10.46% 70.80%
Revenue 452.10% 418.65% 355.29%
Net Income 54.74% -12.00% 75.78%
Cash Flow 40.52% 50.75% 190.36%

Health (49%)

Company Industry
Current Ratio (TTM) 8.45 6.09
Quick Ratio (TTM) 8.45 5.87
D/E Ratio (TTM) N/A 1.00
Interest Coverage (TTM) N/A -9.57
Piotroski F-Score 7 4
Altman Z-Score 2.58 13.84
LTL to 5YR AVG FCF -1.35 0.07
Shares Outstanding Growth 5YR AVG 6.16% 44.11%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙